Heart device study for chronic heart failure
Part of Heart & circulation clinical trials.
This study tests a small device that is implanted under the skin to deliver microcurrents to the heart. It aims to improve heart function and quality of life in people with chronic heart failure who have not improved enough with standard medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- You have chronic heart failure with symptoms like shortness of breath or fatigue.
- Your heart's pumping ability (ejection fraction) is between 20% and 40%.
- You have had a heart failure episode (like a hospital stay or needing extra water pills) in the last year.
- You are on stable heart failure medications for at least 90 days.
- You need to be able to walk for 6 minutes (distance between 100 and 450 meters).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that delivers a gentle electrical current to the heart to improve its pumping strength. It is for people with a certain type of heart failure caused by weak heart muscle, not a blocked artery.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This trial studies a small implant (an “atrial shunt” device) to improve symptoms and heart function in people with chronic left heart failure that stays active despite standard medicines. It focuses on whether the implant is safe and can help you feel better and possibly breathe easier.
This early-phase study tests a lab-made heart tissue (“engineered myocardium”) placed surgically to help the heart work better in people with advanced heart failure. It mainly checks safety first, and also looks for signs the patch can improve heart function in selected patients.
This study tests a therapy called Cardiac Contractility Modulation (CCM) for people with heart failure. It uses a device to help the heart pump more strongly, and researchers compare it to standard care using patient records.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.